Prostate cancer control recorded significant elevation in CEA (810.80 ± 6.67 pg/mL) that was increased more than the negative control by about 2.71 times (299.25 ± 11.22 pg/mL). The gene discussed is CEACAM5; the disease is prostate carcinoma.